What Kind of Person?
November 30, 2012
The Nov. 12, 2012 issue of Fortune magazine asked 21 high-profile people from all walks of life for the one piece of wisdom that got them where they are today. The responses were typical tripe . . . except from Scott Griffith, Chairman and CEO of Zipcar. Griffith said he received this advice from his brother 15 years ago:
"You have to think about what kind of person you want to be when you’re done with this experience. Think about coming out of this a different person than you go in.”
Mr. Griffith got this advice shortly after he was diagnosed with stage 2 Hodgkins lymphoma. But he came to see how this advice could be applied to any challenge – positive or negative – in his or anybody else’s life.
Think how different things would be if Pete Rose had asked this before betting that he could get away with gambling during his Major League Baseball career; or if Mark McGwire, Roger Clemens or others had asked it before the start of their steroid-stained MLB careers.
Which takes me to more recent fallen heroes: Lance Armstrong, and Generals David Petraeus and John Allen. All three have done so much that is so good, most of which has unraveled with their ruined reputations.
If they had only asked, “What kind of person do I want to be when I’m done with this experience?”
They have come out of their experiences different than they went in, but not at all as they had hoped.
We used to say, “No good deed goes unpunished.” It’s also true these days that no bad deed goes undiscovered.
Cardiac Screening
October 31, 2014
Sudden death among 12 to 25-year-olds is “a low event rate occurrence.”
“There is insufficient information to support the view that ECGs in asymptomatic young people for cardiac disease is appropriate or possible on a national basis for the United States, in competitive athletics or in the general population.”
“At present, there is no mechanism available in the United States to effectively create national programs of such magnitude, whether limited to athletics or including the wider population of all young people.”
“There is insufficient evidence that particularly large-scale/mass screening initiatives are feasible or cost effective within the current US healthcare infrastructure . . .”
“The ECG . . . cannot be regarded as an ideal or effective test when applied to large healthy populations.”
“An additional, but unresolved, ethical issue concerns whether students who voluntarily engage in competitive athletic programs should have advantage of cardiovascular screening, while others who choose not to be involved in such activities (but may be at the same or similar risk) are in effect excluded from the same opportunity.”
The AHA’s Sept. 14 AHA writing group “does not believe the available data support significant public health benefit from using the 12-lead ECG as a universal screening tool. The writing group, however, does endorse the widespread dissemination of automated external defibrillators which are effective in saving young lives on the athletic field and elsewhere.”